BioCentury
ARTICLE | Clinical News

Vaprisol conivaptan: Phase III data

September 24, 2007 7:00 AM UTC

Astellas published previously reported data from a double-blind, international Phase III trial in 84 patients in which Conivaptan significantly improved serum sodium levels compared with placebo (p=0....